Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure
- 15 June 2006
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 260 (1) , 11-21
- https://doi.org/10.1111/j.1365-2796.2006.01663.x
Abstract
: Objective. It is well known that chronic heart failure (CHF) is associated with insulin resistance and cachexia, but little is known about the underlying substrate metabolism. The present study was undertaken to identify disturbances of basal glucose, lipid and protein metabolism.Design. We studied eight nondiabetic patients with CHF (ejection fraction 30 ± 4%) and eight healthy controls. Protein metabolism (whole body and regional muscle fluxes) and total glucose turnover were isotopically assayed. Substrate oxidation were obtained by indirect calorimetry. The metabolic response to exercise was studied by bicycle ergometry exercise.Results. Our data confirm that CHF patients have a decreased lean body mass. CHF patients are characterised by (i) decreased glucose oxidation [glucose oxidation (mg kg−1 min−1): 1.25 ± 0.09 (patients) vs. 1.55 ± 0.09 (controls), P < 0.01] and muscle glucose uptake [a − v diffglucose (μmol L−1): −10 ± 25 (patients) vs. 70 ± 22 (controls), P < 0.01], (ii) elevated levels of free fatty acids (FFA) [FFA (mmol L−1): 0.72 ± 0.05 (patients) vs. 0.48 ± 0.03 (controls), P < 0.01] and 3‐hydroxybutyrate and signs of elevated fat oxidation and muscle fat utilization [a − v diffFFA (mmol L−1): 0.12 ± 0.02 (patients) vs. 0.05 ± 0.01 (controls), P < 0.05] and (iii) elevated protein turnover and protein breakdown [phenylalanine flux (μmol kg−1 h−1): 36.4 ± 1.5 (patients) vs. 29.6 ± 1.3 (controls), P < 0.01]. Patients had high circulating levels of noradrenaline, glucagon, and adiponectin, and low levels of ghrelin. We failed to observe any differences in metabolic responses between controls and patients during short‐term exercise.Conclusions. In the basal fasting state patients with CHF are characterized by several metabolic abnormalities which may contribute to CHF pathophysiology and may provide a basis for targeted intervention.Keywords
This publication has 51 references indexed in Scilit:
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart FailureCirculation, 2005
- Mitochondrial Dysfunction and Type 2 DiabetesScience, 2005
- Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart FailureCirculation, 2004
- Acute Exercise has no Effect on Ghrelin Plasma ConcentrationsHormone and Metabolic Research, 2004
- Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 DiabetesCirculation, 2003
- Hemodynamic, Renal, and Hormonal Effects of Ghrelin Infusion in Patients with Chronic Heart FailureJournal of Clinical Endocrinology & Metabolism, 2001
- Stomach Is a Major Source of Circulating Ghrelin, and Feeding State Determines Plasma Ghrelin-Like Immunoreactivity Levels in HumansJournal of Clinical Endocrinology & Metabolism, 2001
- Cellular mechanisms of insulin resistanceJournal of Clinical Investigation, 2000
- Insulin Resistance in Chronic Heart FailureJournal of Cardiovascular Pharmacology, 2000
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUSPublished by Elsevier ,1963